0001658235-15-000002.txt : 20151123 0001658235-15-000002.hdr.sgml : 20151123 20151123135550 ACCESSION NUMBER: 0001658235-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20151123 DATE AS OF CHANGE: 20151123 EFFECTIVENESS DATE: 20151123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abingworth Clinical Co-Development Fund LP CENTRAL INDEX KEY: 0001658235 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-251729 FILM NUMBER: 151249260 BUSINESS ADDRESS: STREET 1: C/O ABINGWORTH LLP STREET 2: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN BUSINESS PHONE: 4402075341500 MAIL ADDRESS: STREET 1: C/O ABINGWORTH LLP STREET 2: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN FORMER COMPANY: FORMER CONFORMED NAME: Abingworth Clinical Co-Development LP DATE OF NAME CHANGE: 20151112 D 1 primary_doc.xml X0707 D LIVE 0001658235 Abingworth Clinical Co-Development Fund LP C/O ABINGWORTH LLP 38 JERMYN STREET LONDON X0 UNITED KINGDOM SW1Y 6DN 4402075341500 UNITED KINGDOM Abingworth Pharmaceutical Co-Development Fund LP Abingworth Clinical Co-Development LP Limited Partnership true 2015 General Partner Abingworth Clinical Co-Development Fund GP LP 50 Lothian Road Festival Square Edinburgh X0 UNITED KINGDOM EH3 9WJ Promoter General Partner of the Issuer Manager Abingworth LLP 38 Jermyn Street London X0 UNITED KINGDOM SW1Y 6DN Promoter Manager of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 false true false true false 0 Asante Capital Group LLP 155178 Asante Capital Group Advisors LLC None 25 Old Burlington Street London X0 UNITED KINGDOM W1S 3AN AK ALASKA AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE FL FLORIDA GA GEORGIA HI HAWAII IL ILLINOIS IN INDIANA KY KENTUCKY LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO OR OREGON PA PENNSYLVANIA SC SOUTH CAROLINA TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN false Indefinite 0 Indefinite false 0 0 true 0 Sales commissions to the placement agent will be equal to a percentage of the aggregate principal amount of securities sold. 0 true The Issuer's General Partner or an affiliate of the Issuer's General Partner may be entitled to receive a management fee in accordance with the Issuer's governing documentation, as amended from time to time. false Abingworth Clinical Co-Development Fund LP /s/ James Foster Abell James Foster Abell Partner of the Manager 2015-11-20